Healthcare & Life Sciences
TenNor Therapeutics
series-b
series-b
Stage
1
Investors
About
TenNor Therapeutics is a clinical-stage company specializing in the discovery and development of differentiated therapies targeting diseases associated with bacterial infection and metabolism.
Explore TenNor Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.